Table 6.

Odds ratios (95% confidence intervals) of somatic diseases/disorders (lifetime prevalence) regressed on immune-mediated classes, men and women

	Neutral class	Resilient class	Atopic class	Mixed class	ACE class
Men
Ulcer	1 (ref.)	1.6 (1.1–2.3)	1.0 (0.4–2.1)	0.7 (0.3–1.6)	0.7 (0.3–2.1)
Irritable bowel syndrome	1 (ref.)	1.0 (0.5–2.1)	3.0 (1.3–7.0)	2.5 (1.1–5.6)	1.1 (0.3–4.8)
Cystitis	1 (ref.)	0.7 (0.4–1.3)	3.2 (1.8–5.7)	3.3 (1.9–5.5)	1.5 (0.6–3.6)
Acne	1 (ref.)	0.7 (0.5–1.1)	1.4 (0.8–2.5)	1.8 (1.1–2.8)	0.7 (0.3–1.7)
Psoriasis	1 (ref.)	0.7 (0.4–1.1)	0.3 (0.1–1.2)	1.3 (0.7–2.5)	1.2 (0.5–2.9)
Migraine	1 (ref.)	1.1 (0.7–1.6)	1.8 (1.1–3.2)	2.3 (1.5–3.6)	1.3 (0.6–2.6)
Women
Ulcer	1 (ref.)	1.3 (0.8–2.1)	1.5 (0.8–2.9)	1.4 (0.8–2.5)	3.1 (1.8–5.4)
Irritable bowel syndrome	1 (ref.)	1.5 (0.9–2.4)	2.0 (1.1–3.8)	2.9 (1.8–4.8)	3.7 (2.1–6.6)
Cystitis	1 (ref.)	1.0 (0.8–1.2)	2.1 (1.5–2.8)	1.9 (1.5–2.5)	2.2 (1.5–3.0)
Acne	1 (ref.)	0.9 (0.6–1.3)	1.1 (0.6–1.7)	1.5 (1.0–2.2)	1.8 (1.1–2.8)
Psoriasis	1 (ref.)	0.9 (0.5–1.5)	1.0 (0.5–2.1)	0.9 (0.5–1.8)	1.6 (0.8–3.2)
Migraine	1 (ref.)	0.9 (0.7–1.2)	1.7 (1.2–2.4)	1.2 (0.9–1.7)	1.2 (0.8–1.8)

ACE adverse childhood experiences